WASHINGTON, D.C. – Today, Senator Thom Tillis (R-NC) issued the following statement on the FDA’s recent announcement on tobacco and vapor products: 

“I applaud the FDA’s commitment to developing a robust plan to combat underage use of e-vapor products. However, I hope the FDA revisits some of its actions affecting traditional products that have been marketed for decades. The FDA must remain committed to using a science-based regulatory framework in order to effectively reduce risks and minimize collateral damage that would ultimately limit options available to adults seeking an alternative to smoking.” 

###